Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...

The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...

Decongestants can help you feel less stuffed up by reducing swelling in the nasal passages, said Voigt. These include oral ...

A panel last year said it found evidence the ingredient, used in many popular medicines, did not aid with nasal congestion.

Yesterday, US health officials proposed getting rid of oral drugs containing the decongestant phenylephrine over concerns ...

A phase 3 study has shown that when compared with placebo, Tezspire provided a statistically significant and clinically ...

Share on Facebook Share on Twitter The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the ...

by AstraZeneca and Amgen has shown significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP), ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...